Comorbid anxiety is common in patients with bipolar disorder. This comorbidity is associated with increased disease severity and poorer treatment response. A study with lurasidone 20-60 mg/day showed significant efficacy against depressive and anxiety symptoms, regardless of baseline anxiety level.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Incontinence
Fecal incontinence from the perspective of gastroenterology
- HER2-positive breast cancer
ENPP1 as a biomarker for poor prognosis and early detection of brain metastases
- Update 2025
Hypercholesterolemia
- GPP: from molecular principles to targeted therapy
Therapeutic rationale for targeted IL-36 receptor inhibition
- HFpEF 2025
Precision medicine and phenotypes
- Myelofibrosis